Rocuronium Bromide Injection — FDA Drug Shortage

Current — Mylan Institutional, A Viatris Company

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Feb 15, 2023.

Shortage details

Status
Current
Company
Mylan Institutional, A Viatris Company
Package NDC
67457-228-10
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)
Initial Posting
Feb 15, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.